Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma

The purpose of the present study was to develop oral dispersible tablets containing prednisolone (PDS)-loaded chitosan nanoparticles using microcrystalline cellulose (MCC 101), lactose, and croscarmellose sodium (CCS). The PDS-loaded chitosan nanoparticles were formulated by ionotropic external gela...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Autores principales: Chen, Yi-Dan, Liang, Zhong-Yuan, Cen, Yan-Yan, Zhang, He, Han, Mei-Gui, Tian, Yun-Qiao, Zhang, Jie, Li, Shu-Jun, Yang, Da-Sheng
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662371/
https://ncbi.nlm.nih.gov/pubmed/26640367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S86075
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares